Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gladek, A.
Right arrow Articles by Liehr, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gladek, A.
Right arrow Articles by Liehr, J. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 Oxford University Press

research-article

Transplacental genotoxicity of diethylstilbestrol

Alicja Gladek and Joachim G. Liehr

Department of Pharacology and Toxicology, University of Texas Medical Branch Galveston, Texas 77550–2782, USA

Diethylstilbestrol (DES) is a transplacental carcinogen in humans and in rodents. As part of an attempt to examine the mechanism of transplacental carcinogenesis, the transplacental genotoxity of this stilbene estrogen has been investigated. Pregnant hamsters received single injections of 200 mg/kg DES on the 10th day of gestation and were killed 5 or 24 h after treatment. The maternal organs were found to contain the same DES-DNA adduct patterns observed previously by 32P-postlabeling analysis in female hamsters. These adduct patterns, generated by the genotoxic metabolite diethylstilbestrol-4', 4''-quinone (DES Q), were also observed in fetal heart and kidney DNA. In fetal liver DNA, this modified nucleotide, generated by the quinone, was only the minor adduct. The major DNA adduct in this organ was not observed previously and may have been generated by an unknown DES metabolite. The data demonstrate that DES is a transplacentally active genotoxic agent. They also provide evidence for fetal metabolism of DES to DES Q and to other unknown genotoxic intermediates.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
P. A. McAnulty and M. Skydsgaard
Diethylstilbestrol (DES): Carcinogenic Potential in Xpa-/-, Xpa-/-/p53+/-, and Wild-Type Mice During 9 Months' Dietary Exposure
Toxicol Pathol, August 1, 2005; 33(5): 609 - 620.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
P. L. Carmichael, J. J. Mills, M. Campbell, M. Basu, and J. Caldwell
Mechanisms of Hormonal Carcinogenesis in the p53+/- Hemizygous Knockout Mouse: Studies With Diethylstilbestrol
Toxicol Pathol, January 1, 2001; 29(1_suppl): 155 - 160.
[Abstract] [PDF]

Home page
 CarcinogenesisHome page
R. R. Newbold, R. B. Hanson, W. N. Jefferson, B. C. Bullock, J. Haseman, and J. A. McLachlan
Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol
Carcinogenesis, July 1, 2000; 21(7): 1355 - 1363.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.